Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Nov 30, 2015 at 1:10 PM EST

Anavex Takes Off on Positive Alzheimer’s Data

Anavex Life Sciences announced the publication of further data for Anavex 3-71 in the peer-reviewed scientific journal Neurodegenerative Diseases.

Chris Lange | Nov 28, 2015 at 10:16 AM EST

4 Key FDA Decisions Expected By Year End

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There…

Chris Lange | Nov 25, 2015 at 9:06 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the short interest data on the top biotech companies.

Lee Jackson | Nov 24, 2015 at 10:47 AM EST

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the…

Jon C. Ogg | Nov 23, 2015 at 2:25 PM EST

Analysts Start MyoKardia With Positive Ratings

MyoKardia, Inc. (NASDAQ: MYOK) has now moved far enough beyond the October 28 IPO pricing that the analysts in the…

Jon C. Ogg | Nov 23, 2015 at 1:01 PM EST

Why Goldman Sachs Sees Serious Upside for Teva for 2016

Teva Pharmaceutical Industries Limited (NYSE: TEVA) had a very hard time getting off the ground from 2011 through the start…

Chris Lange | Nov 23, 2015 at 12:09 PM EST

Can-Fite Soars on Positive Phase 2 Developments

Biotech company Can-Fite announced development of its drug candidate CF102, which is currently in phase 2 trials for liver cancer,…

Chris Lange | Nov 23, 2015 at 9:00 AM EST

Mallinckrodt Impresses on Top and Bottom Line Results

Mallinckrodt PLC (NYSE: MNK) reported its fiscal fourth-quarter financial results before the markets opened on Monday. The company had $1.84…

Chris Lange | Nov 21, 2015 at 10:25 AM EST

6 BioHealth Movers That Now Cannot Be Ignored

24/7 Wall St. examines Valeant Pharmaceuticals and other biotech stocks with incredible gains or losses over the course of the…

Paul Ausick | Nov 21, 2015 at 9:15 AM EST

Biotech Industry Study Reports Big Gains in M&A, IPOs

Consulting firm BDO USA's "2015 BDO Biotech Briefing" examined recent annual report filings of stocks included on the Nasdaq Biotechnology…

Jon C. Ogg | Nov 20, 2015 at 11:05 AM EST

Anthem Affirms Guidance

Anthem is trying to convey the message that the problems of UnitedHealth Group are not its problem. At least that…

Lee Jackson | Nov 20, 2015 at 9:35 AM EST

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

A new Jefferies research report highlights four top companies that could be looking at catalysts that in the very near…

Chris Lange | Nov 19, 2015 at 12:15 PM EST

Axsome Therapeutics Quietly Enters Market in IPO

Axsome Therapeutics entered the market on Thursday morning at a price below the previously announced expected pricing range.

Chris Lange | Nov 19, 2015 at 12:10 PM EST

Celladon Soars on Proposed Merger Agreement

Celladon and Eiger BioPharmaceuticals have announced that they have entered into a definitive merger agreement.

Jon C. Ogg | Nov 19, 2015 at 11:50 AM EST

UnitedHealth Warning Creates Huge Spillover, With Big Implications Ahead

We have word from UnitedHealth Group in an earnings warning that could be a serious blow to at least part…

1 … 233 234 235 236 237 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Anavex Takes Off on Positive Alzheimer’s Data

4 Key FDA Decisions Expected By Year End

Short Sellers Run for Cover From Major Biotechs

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Analysts Start MyoKardia With Positive Ratings

Why Goldman Sachs Sees Serious Upside for Teva for 2016

Can-Fite Soars on Positive Phase 2 Developments

Mallinckrodt Impresses on Top and Bottom Line Results

6 BioHealth Movers That Now Cannot Be Ignored

Biotech Industry Study Reports Big Gains in M&A, IPOs

Anthem Affirms Guidance

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

Axsome Therapeutics Quietly Enters Market in IPO

Celladon Soars on Proposed Merger Agreement

UnitedHealth Warning Creates Huge Spillover, With Big Implications Ahead

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Health and Healthcare Articles

All Health and Healthcare Articles

Anavex Takes Off on Positive Alzheimer’s Data

4 Key FDA Decisions Expected By Year End

Short Sellers Run for Cover From Major Biotechs

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Analysts Start MyoKardia With Positive Ratings

Why Goldman Sachs Sees Serious Upside for Teva for 2016

Can-Fite Soars on Positive Phase 2 Developments

Mallinckrodt Impresses on Top and Bottom Line Results

6 BioHealth Movers That Now Cannot Be Ignored

Biotech Industry Study Reports Big Gains in M&A, IPOs

Anthem Affirms Guidance

4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming

Axsome Therapeutics Quietly Enters Market in IPO

Celladon Soars on Proposed Merger Agreement

UnitedHealth Warning Creates Huge Spillover, With Big Implications Ahead

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation